
Sign up to save your podcasts
Or
Can cell therapy revolutionize hearing loss treatment? In this follow-up discussion, Brian Culley, CEO of Lineage Cell Therapeutics, shares exciting updates on the ReSonance™ (ANP1) program, a pioneering preclinical study exploring auditory neuron cell transplantation. Culley explains how lab-grown auditory neurons are being delivered to the inner ear to potentially restore damaged auditory pathways—a groundbreaking approach that could even complement existing treatments.
For more information on the ReSonance program, visit the company's website here.
5
11 ratings
Can cell therapy revolutionize hearing loss treatment? In this follow-up discussion, Brian Culley, CEO of Lineage Cell Therapeutics, shares exciting updates on the ReSonance™ (ANP1) program, a pioneering preclinical study exploring auditory neuron cell transplantation. Culley explains how lab-grown auditory neurons are being delivered to the inner ear to potentially restore damaged auditory pathways—a groundbreaking approach that could even complement existing treatments.
For more information on the ReSonance program, visit the company's website here.
30,293 Listeners
6,344 Listeners
68,440 Listeners
1,721 Listeners
2,799 Listeners
2,526 Listeners
2 Listeners
16 Listeners
23 Listeners
8,385 Listeners
596 Listeners
12,328 Listeners
14,859 Listeners